APA (7th ed.) Citation

Mattei, J., Ballhausen, A., Bassett, R., Shephard, M., Chattopadhyay, C., Hudgens, C., . . . Patel, S. P. (2020). A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma. Melanoma research, 30(6), . https://doi.org/10.1097/CMR.0000000000000694

Chicago Style (17th ed.) Citation

Mattei, Jane, et al. "A Phase II Study of the Insulin-like Growth Factor Type I Receptor Inhibitor IMC-A12 in Patients with Metastatic Uveal Melanoma." Melanoma Research 30, no. 6 (2020). https://doi.org/10.1097/CMR.0000000000000694.

MLA (9th ed.) Citation

Mattei, Jane, et al. "A Phase II Study of the Insulin-like Growth Factor Type I Receptor Inhibitor IMC-A12 in Patients with Metastatic Uveal Melanoma." Melanoma Research, vol. 30, no. 6, 2020, https://doi.org/10.1097/CMR.0000000000000694.